The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy

Metabolic syndrome refers to a set of conditions that increases the risk of cardiovascular disease and has been associated with an increased risk of prostate cancer, particularly among African American men. This study aimed to estimate the association of metabolic syndrome with biochemical recurrenc...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer M. Post, Jennifer L. Beebe-Dimmer, Hal Morgenstern, Christine Neslund-Dudas, Cathryn H. Bock, Nora Nock, Andrew Rundle, Michelle Jankowski, Benjamin A. Rybicki
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2011/245642
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metabolic syndrome refers to a set of conditions that increases the risk of cardiovascular disease and has been associated with an increased risk of prostate cancer, particularly among African American men. This study aimed to estimate the association of metabolic syndrome with biochemical recurrence (BCR) in a racially diverse population. Among 383 radical prostatectomy patients, 67 patients had documented biochemical recurrence. Hypertension was significantly, positively associated with the rate of BCR (hazard ratio (HR) = 2.1; 95%  CI = 1.1, 3.8). There were distinct racial differences in the prevalence of individual metabolic syndrome components; however, the observed associations with BCR did not differ appreciably by race. We conclude that hypertension may contribute to a poorer prognosis in surgically treated prostate cancer patients. Our findings suggest that targeting components of the metabolic syndrome which are potentially modifiable through lifestyle interventions may be a viable strategy to reduce risk of BCR in prostate cancer.
ISSN:2090-3111
2090-312X